Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Blackstone's GRIN inks epilepsy licensing deal with Angelini, closes $140M Series D
Last month
Deals
Trump asks 'very tough hombre' Dr. Oz to lead MFN talks
Last month
US warns drugmakers against misrepresenting cost of imported products
Last month
Manufacturing
Law
CHMP clears path for GSK’s Blenrep relaunch, recommends four other drugs
Last month
FDA+
Gilead notches another Phase 3 win for Trodelvy in triple-negative breast cancer
Last month
R&D
GSK’s Nucala wins COPD approval, stoking rivalry with Dupixent
Last month
FDA+
Roche confirms overall survival benefit for PI3K inhibitor in breast cancer
Last month
R&D
Jazz outlines full survival data for lung cancer drug Zepzelca
Last month
R&D
House passes Trump tax bill with PBM and orphan drug reforms included
Last month
Law
Cigna, Novo offer lower GLP-1 prices to lure patients to brand-name drugs
Last month
Health Tech
The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry
Last month
FDA+
Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact
Last month
Manufacturing
Sanofi makes $470M move for Vigil's Alzheimer's drug, while another asset returns to Amgen
Last month
Deals
FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo
Last month
FDA+
FDA asks Covid vaccine makers to add more myocarditis data to labels
Last month
FDA+
FDA announces efforts to facilitate drug importation from Canada
Last month
FDA+
Manufacturing
Teva, Novartis get fresh warnings from FTC over Orange Book patent listings
Last month
Law
FDA adcomm narrowly votes against UroGen’s bladder cancer drug, calls for RCTs
Last month
FDA+
RFK Jr. spars with senators over research cuts, HHS budget plan
Last month
FDA+
Updated: Trump administration reveals 'most favored nation' drug price country targets
Last month
Law
Pfizer joins PD-1xVEGF race with $1.25B upfront to Chinese biotech 3SBio
Last month
Deals
China
Stelara biosimilars look to gain traction, helped by recent lessons from Humira
Last month
Intellia's CRISPR therapy likely causes 'permanent' gene knockdown in ATTR amyloidosis
Last month
R&D
Cell/Gene Tx
Regeneron plans to buy 23andMe for $256M
Last month
Deals
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page